Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVelocity Comp Regulatory News (VEL)

Share Price Information for Velocity Comp (VEL)

Share Price is delayed by 15 minutes
Get Live Data
13.00    0.00 (0.00%)
Bid:
12.00
Ask:
14.00
Spread: 2.00 (16.667%)
Market Cap: £7.11m
VEL Live PriceLast checked at - London Stock Exchange

Intraday Velocity Comp Share Chart

Director Dealings

1 Feb 2011 08:26

RNS Number : 4388A
Velti PLC
01 February 2011
 



 

February 1, 2011

Velti Announces Director Dealings

DUBLIN, Ireland and SAN FRANCISCO, Feb. 1, 2011 -- Velti plc (Nasdaq:VELT - News), a leading mobile marketing and advertising technology provider for brands, advertising agencies, mobile operators and media, today announced that on January 28, 2011, the following Non-Executive Directors, Executive Directors, and Executive Officers sold an aggregate of 1,105,000 of our ordinary shares of 5p each, at a price to the public of $12.00 each, in connection with our initial public offering in the United States. The number of shares sold by each director and executive officer, and the beneficial ownership in Velti following each such sale, is set forth in the table below, which is based on information concerning our outstanding ordinary shares as of December 31, 2010:

Shares BeneficiallyOwned Prior to theOffering

Number ofShares Sold

Number of Shares Beneficially Owned After the Offering

 

Name of Beneficial Owner

Number(1)

Percent(1)

Number

Percent

 

Alex Moukas(1)

4,132,398

10.8

%

400,000

3,732,398

7.3

%

 

Chris Kaskavelis(1)

4,632,901

12.1

%

400,000

4,232,901

8.3

%

 

Menelaos Scouloudis(1)

1,862,078

4.9

%

200,000

1,662,078

3.3

%

 

Jerry Goldstein(2)

404,419

1.1

%

37,000

367,419

0.07

%

 

Nicholas P. Negroponte(2)

760,598

2.0

%

68,000

692,598

1.4

%

 

(1) In addition to the shares beneficially owned as set forth in the table above, each of our executive officers have been awarded certain share options and deferred shares subject to vesting provisions. If all such share options and deferred shares were to vest, then Messrs. Moukas, Kaskavelis, and Scouloudis would beneficially own 4,930,478, 5,240,587, and 2,411,290 shares, respectively.

(2) In addition to the shares beneficially owned as set forth in the table above, each of our non-executive directors have been awarded deferred shares subject to vesting provisions. If all such deferred shares were to vest, then Messrs. Goldstein and Negroponte would beneficially own 428,041, and 784,220 shares, respectively.

In the table above, the column entitled "Shares Beneficially Owned Prior to the Offering - Percent" is based on 38,300,792 ordinary shares outstanding as of December 31, 2010. The columns entitled "Shares Beneficially Owned After the Offering - Percent" is based on 50,800,792 ordinary shares to be issued and outstanding immediately after closing of our initial public offering in the United States, following the exercise of the underwriters' over-allotment option and the sale of all of the selling shareholders' eligible shares.

Beneficial ownership is determined in accordance with the rules and regulations of the SEC. In computing the number of shares beneficially owned by a person and the percentage ownership of that person, we have included shares that the person has the right to acquire within 60 days, including through the vesting of deferred share awards, exercise of any option, warrant or other right or the conversion of any other security.

Velti ordinary shares began trading on the NASDAQ Global Select Market on January 28, 2011 under the symbol "VELT." Jefferies & Company, Inc. is acting as the sole book-running lead manager for the offering. Needham & Company LLC, RBC Capital Markets Corp., Canaccord Genuity Inc., and ThinkEquity LLC are acting as co-managers.

A registration statement relating to our initial public offering in the United States was declared effective by the Securities and Exchange Commission on January 27, 2011. Our initial public offering in the United States is being made solely by means of a written prospectus forming part of the effective registration statement. Copies of the final prospectus relating to our initial public offering in the United States may be obtained from: Jefferies & Company, Inc., Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, NY 10022, telephone: (877) 547-6340, email: Prospectus_Department@Jefferies.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

For further information, please contact:

 

Bankside Consultants

Simon Bloomfield simon.bloomfield@bankside.com

+44 (0) 207 367 8861

 

The Blueshirt Group

Mike Bishop

mike@blueshirtgroup.com

+1 (415) 217 4968

 

RBC Capital Markets

(NOMAD and Broker)

Joshua Critchley

Matthew Coakes

Daniel Conti

+44 (0) 207 653 4000

 

Velti plc

Dakota Sullivan

VP, Global Marketing

dsullivan@velti.com

+1 (415) 315 3436

 

Jefferies & Company, Inc.

Attention: Equity Syndicate Prospectus Department

520 Madison Avenue

New York, NY 10022

(877) 547-6340

Prospectus_Department@Jefferies.com

 

 

About Velti

Velti is a provider of mobile marketing and advertising solutions that enable brands, advertising agencies, mobile operators and media to implement campaigns by communicating with and engaging consumers via their mobile devices. Velti is a publicly-held corporation based in Jersey and trades on the NASDAQ Global Select Market under the symbol VELT and the London Stock Exchange's AIM under the symbol VEL.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGIGDDBDGBGBB
Date   Source Headline
24th Jun 20267:00 amRNSHalf-year Financial Report
18th Jun 20267:00 amRNS-RNotice of Investor Presentation
26th May 20267:00 amRNSTrading Statement
6th May 20269:07 amRNSHolding(s) in Company
23rd Apr 20267:00 amRNSBoard Change
23rd Mar 20262:18 pmRNSGrant of Share Options to Directors/PDMRs
17th Mar 202611:11 amRNSResult of AGM
9th Feb 202612:15 pmRNSChange of Joint Broker
27th Jan 202612:42 pmRNSReplacement - Audited Final Results
27th Jan 20267:00 amRNSFinal Results to the 31 October 2025
13th Jan 20263:49 pmRNS-RNotice of Investor Presentation - Replacement
8th Jan 20267:00 amRNS-RNotice of Investor Presentation
27th Nov 202510:19 amRNSPDMR/Director shareholding
25th Nov 202511:18 amRNSGrant of Share Options to Directors/PDMRs
5th Nov 20257:00 amRNSTrading Update
8th Oct 20257:00 amRNSContract Renewal and Expansion
8th Jul 202510:43 amRNSExercise of Share Options and Issue of Equity
25th Jun 20257:00 amRNSUnaudited Half Year Results
29th May 20257:00 amRNS-RNotice of Investor Presentation
22nd May 20257:00 amRNSTrading Update & Notice of Results
14th May 20253:16 pmRNSExercise of Share Options and Issue of Equity
12th May 20257:00 amRNSRenewal of BAE Systems Contract
6th May 20254:53 pmRNSHolding(s) in Company
6th May 202510:41 amRNSHolding(s) in Company
29th Apr 20255:26 pmRNSExercise of Share Options and Issue of Equity
28th Apr 20254:37 pmRNSPublication of Annual Report and Accounts
28th Mar 20252:49 pmRNSExercise of Share Options and Issue of Equity
17th Mar 20251:51 pmRNSDirector/PDMR Shareholding
11th Mar 202512:15 pmRNSResult of AGM
5th Mar 202510:53 amRNSDirector/PDMR Shareholding
4th Feb 20257:00 amRNS-RAppointment of Chief Operations Officer
3rd Feb 20257:00 amRNSGrant of Share Options
29th Jan 20257:00 amRNSAudited Final Results to 31 October 2024
15th Jan 20257:00 amRNS-RNotice of Investor Presentation
24th Dec 20247:00 amRNSDirector/PDMR Shareholding
20th Dec 20243:26 pmRNSExercise of Share Options and Issue of Equity
12th Dec 20247:00 amRNSTrading Update & Notice of Results
4th Nov 20244:43 pmRNSDirector/PDMR Shareholding
1st Nov 20247:00 amRNSTotal Voting Rights
7th Oct 20247:00 amRNSDirector/PDMR Shareholding
26th Sep 20245:48 pmRNSExercise of Share Options and Issue of Equity
18th Sep 20247:00 amRNSTrading Update
17th Jul 202410:16 amRNSHolding(s) in Company
17th Jul 20247:00 amRNSGrant of Share Options
16th Jul 20247:00 amRNSDirector/PDMR Shareholding
9th Jul 20247:00 amRNSHalf-Year Results
22nd May 20247:00 amRNSTrading Update & Notice of Results
13th May 20245:12 pmRNSReplacement: Holding(s) in Company
13th May 20242:31 pmRNSHolding(s) in Company
2nd May 20247:00 amRNSChange of Nominated Adviser and Corporate Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.